Insider · CIK 0001782999
PureTech Health plc
Files at AKLI (Akili, Inc.), SPTX (Seaport Therapeutics, Inc.). First filing -, latest -.
In brief
PureTech Health plc files SEC Form 4 as 10% owner at AKLI (Akili, Inc.), and also at SPTX (Seaport Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; PureTech Health plc has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Common Stockindirect: See footnote | +12,736,014 | - | - | 13,038,493 | May 6, 2026 |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Common Stockindirect: See footnote | +2,681,265 | - | - | 15,719,758 | May 6, 2026 |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Common Stockindirect: See footnote | +965,255 | - | - | 16,685,013 | May 6, 2026 |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Series A-1 Preferred Stockderivativeindirect: See footnote | -40,000,000 | $0.00 | $0 | 0 | May 6, 2026 |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Series A-2 Preferred Stockderivativeindirect: See footnote | -8,421,052 | $0.00 | $0 | 0 | May 6, 2026 |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Series B Preferred Stockderivativeindirect: See footnote | -3,031,578 | $0.00 | $0 | 0 | May 6, 2026 |
| Jul 2, 2024 | AKLI Akili, Inc. | UTender of shares Common Stockindirect: See footnote | -12,527,477 | - | - | 0 | Jul 8, 2024 |
Questions about PureTech Health plc
Answered from the filings on this page, as of the latest one.
Is PureTech Health plc buying or selling?
PureTech Health plc has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did PureTech Health plc's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and PureTech Health plc has 0.
Where does PureTech Health plc file Form 4?
PureTech Health plc has filed Form 4 at AKLI (Akili, Inc.); SPTX (Seaport Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.